Assessing postsurgery body mass index reduction and identifying factors associated with greater body mass index reduction in a sample of obese patients who underwent weight-loss surgery in Saudi Arabia

Ahmed, Anwar; Alanazi, Wala R; Ahmed, Rayan A; AlJohi, Wijdan; Buraikan, Doaa A Al; Rasheed, Budor A Al; Muqbil, Bashayr I Al; Bawazir, Amen; Shehri, Ali Al; Al‐Jahdali, Hamdan

doi:10.4103/ssj.ssj_21_18

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous literature reported a substantial reduction of BMI associated with HbA1c reduction within 12 months, and we noted similar results, but within 10 months [ 23 , 25 , 26 ]. Lee et al (2009) found remission of diabetes in poorly controlled patients with a 22.8% reduction in HbA1c after LSG.…”

Section: Discussionsupporting

confidence: 87%

“…A study done by Ahmed et al (2018) reported that patients with BMI >40 kg/m 2 had a significant reduction in weight within 12 months after LSG, with a 25% reduction of weight postoperatively [ 23 ]. Also, Ahmed et al (2018) and Sucandy et al (2013) reported a significant postoperative reduction of BMI and improved glycemic control at one year following LSG [ 25 , 26 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Effect of Bariatric Surgery on Glycaemic Control in King Fahad Hospital

Zaki¹,

Alhelali²,

Samman³

et al. 2021

Cureus

View full text Add to dashboard Cite

Background: Laparoscopic Sleeve Gastrectomy (LSG) is an approved procedure for weight reduction in obese patients. This outcome of weight loss is essential to achieve optimal control in patients with type 2 diabetes mellitus (T2DM). Objectives: This study was designed to evaluate the effect of LSG on glycemic control among a sample of obese patients in Al-Madinah Al-Munawwarah, Saudi Arabia, through assessment of reduction in hemoglobin A1c (HbA1c) associated with weight loss following LSG. Methods: In this cross-sectional study, we studied 102 patients with a body mass index (BMI) of ≥30 kg/m 2 and aged ≥18 years who underwent LSG between January 2017 and December 2019. Patient age, characteristics, preoperative and postoperative records of BMI and HbA1c were collected. The data of BMI and HbA1c were analyzed based on baseline and mean postoperative readings with variable postoperative visits after LSG. Results: There was a 30% reduction in BMI and a 26.4% reduction in HbA1c following LSG from baseline in all patients. We noted 44 patients achieved BMI <40kg/m 2 with HbA1c <6.5% and 32 patients achieved BMI <40kg/m 2 with HbA1c <5.7% within a mean follow-up time of 10 months. Conclusions: Laparoscopic Sleeve Gastrectomy (LSG) has a positive effect on glycemic control in obese patients in short term, evidenced by the significant reduction of weight and HbA1c. Larger longitudinal studies are needed to assess the long-term impact of LSG glycemic control and the related factors associated with maintaining weight reduction and optimal glycemic control in Saudi Arabia for patients with obesity.

show abstract

Section: Discussionsupporting

confidence: 87%